Eiger BioPharmaceuticals, Inc.
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION

Last updated:

Abstract:

Tipifarnib or a tipifarnib derivative is used to treat HDV infection as a monotherapy or in combination with an interferon and/or boosting agent such as a CYP3A4 inhibitor such as ritonavir and cobicistat.

Status:
Application
Type:

Utility

Filling date:

10 Mar 2021

Issue date:

27 Jan 2022